Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients (Q33451134)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients |
scientific article |
Statements
1 reference
Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients (English)
1 reference
R L Dobbins
1 reference
R O'Connor-Semmes
1 reference
A Kapur
1 reference
C Kapitza
1 reference
G Golor
1 reference
I Mikoshiba
1 reference
W Tao
1 reference
E K Hussey
1 reference
30 October 2011
1 reference
1 reference
14
1 reference
15-22
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference